Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 47 TWD 0.21%
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Maxigen Biotech Inc

There are no price targets for Maxigen Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Maxigen Biotech Inc Competitors:
Price Targets
300791
Sirio Pharma Co Ltd
10% Upside
300957
Yunnan Botanee Bio-Technology Group Co Ltd
29% Upside
SIS
Science in Sport PLC
13% Upside
4919
Milbon Co Ltd
2% Upside
COLPAL
Colgate-Palmolive (India) Ltd
16% Upside
ICOS
Intercos SpA
31% Upside
4190
Jourdeness Group Ltd
198% Upside
051900
LG H&H Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Maxigen Biotech Inc

For the last 8 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 5 years is -6%.

11%
Past Growth
-6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 5 years is -16%.

N/A
Past Growth
-16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 5 years is -14%.

N/A
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Maxigen Biotech Inc's stock price target?
Not Available

Maxigen Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is Maxigen Biotech Inc's Revenue forecast?
Projected CAGR
-6%

For the last 8 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 5 years is -6%.

What is Maxigen Biotech Inc's Operating Income forecast?
Projected CAGR
-16%

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 5 years is -16%.

What is Maxigen Biotech Inc's Net Income forecast?
Projected CAGR
-14%

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 5 years is -14%.

Back to Top